Prostate Cancer Clinical Trial

Clinical Trial Finder Prostate Cancer Trials

Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer

See Locations Near You

Summary

The purpose of this study is to learn if men with metastatic prostate cancer and rising Prostate Specific Antigen (PSA), who have been surgically castrated or are undergoing androgen deprivation with Luteinizing Hormone Releasing Hormone (LHRH) treatment, respond to dasatinib. The safety of this treatment will also be studied.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

males, 18 or older
proven advanced prostate cancer
documented metastatic disease
rising PSA levels
castrate levels of testosterone

Exclusion Criteria:

symptomatic CNS (brain or spinal cord) metastasis
medical condition which may increase the risk of toxicity
any prior or ongoing anti-cancer medical therapy or immunotherapy for prostate cancer other than primary androgen deprivation agents
unable to take oral medication

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

94

Study ID:

NCT00385580

Recruitment Status:

Completed

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 11 Locations for this study

See Locations Near You

Cedars Sinai Medical Center
Los Angeles California, 90048, United States
University Of Chicago
Chicago Illinois, 60637, United States
The Bunting Blaustein Cancer Research Building
Baltimore Maryland, 21231, United States
Memorial Sloan-Kettering Cancer Center-Sidney Kimmel Center
New York New York, 10021, United States
Fox Chase Cancer Center
Philadelphia Pennsylvania, 19111, United States
Seattle Cancer Care Alliance
Seattle Washington, 98109, United States
University Of Wisconsin Paul P Carbone Comprehensive Ca Ctr
Madison Wisconsin, 53792, United States
Local Institution
Montpellier , 34298, France
Local Institution
Paris , 75015, France
Local Institution
Villejuif Cedex , 94800, France
Local Institution
Rome , 00152, Italy
Load More

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

94

Study ID:

NCT00385580

Recruitment Status:

Completed

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider